window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 21, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

data management

  • Digital & Data

    AI adoption grows in life science labs but data integration remains a barrier, survey finds

    More than 60% of life science laboratories are exploring or [...]

    June 19, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain

    Evestia Clinical acquires ICRC-Weyer to expand full-service clinical research in Europe

    Evestia Clinical has acquired Berlin-based CRO and scientific consultancy ICRC-Weyer [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Gap emerges between agentic AI ambition and real-world use in pharma, report finds

    A growing gap has emerged between how life sciences and [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Veeva announces expanded partnership with Roche to deliver next-generation AI CRM

    Veeva Systems has extended its partnership with Roche Pharmaceuticals by [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Adneuris licenses Phase 3 pain therapy cebranopadol to Conba for Greater China
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • Latent Labs opens lab-validated AI drug design platform to researchers worldwide
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
  • PET imaging reveals widespread synaptic loss in schizophrenia
    Categories: Clinical & Regulatory, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top